Compounds > 17-alpha-hydroxyprogesterone
Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and fludrocortisone

17-alpha-hydroxyprogesterone has been researched along with fludrocortisone in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19904 (16.00)18.7374
1990's3 (12.00)18.2507
2000's7 (28.00)29.6817
2010's8 (32.00)24.3611
2020's3 (12.00)2.80

Authors

AuthorsStudies
Arisaka, M; Arisaka, O; Hosaka, A; Nakayama, Y; Shimura, N; Yabuta, K; Yamashiro, Y1
Arisaka, M; Arisaka, O; Nakayama, Y; Shimura, N; Yabuta, K1
Couch, RM; Winter, JS1
Mellinger, RC; Wisgerhof, M; Zafar, MS1
Anderson, JM; Griffiths, KD; Holder, G; Rayner, PH; Rudd, BT; Virdi, NK1
Argenziano, A; Di Maio, S; Franzese, A; Gasparini, N; Salerno, M; Tenore, A1
Hughes, IA; Premawardhana, LD; Read, GF; Scanlon, MF1
Bonjer, J; Bootsma, AH; Bruining, H; de Jong , FF; Koper, JW; Lamberts, SW1
De Luca, F; Lombardo, F; Valenzise, M; Wasniewska, M1
Calis, KA; Cho, D; Chrousos, GP; Keil, MF; Merke, DP1
Brook, CG; Charmandari, E; Hindmarsh, PC; Johnston, A; Matthews, DR1
Diederich, S; Meyer, B; Oelkers, W; Quinkler, M1
Bennek, J; Hoepffner, W; Keller, E; Schulze, E; Willgerodt, H1
Merke, DP1
Claahsen-van der Grinten, HL; Kapusta, L; Mooij, CF; Otten, BJ1
Himes, JH; Lacey, JM; Matern, D; Netzel, BC; Sarafoglou, K; Singh, RJ1
Grebe, SK; Lorentz, CP; Oetting, WS; Otten, N; Sarafoglou, K1
Seth, A; Sharma, R1
Fujimoto, M; Hanaki, K; Kanzaki, S; Kawashima, Y; Miyahara, N; Nishimura, R; Usui, T1
Dey, AC; Dey, SK; Khan, KA; Mannan, MA; Nahar, N; Shahidullah, M1
Gonzalez-Bolanos, MT; Hindmarsh, PC; Kyllo, J; Lteif, A; Maccabee-Ryaboy, N; Petryk, A; Sarafoglou, K; Thomas, W1
Gangodkar, P; Khadilkar, A; Khadilkar, V; Maheshwari, A1
Adhikari, U; Khanal, D; Mandal, D; Phuyal, R1
Arlt, W; Brac de la Perriere, A; Coope, H; Juul, A; Linden Hirschberg, A; Mallappa, A; Merke, DP; Newell-Price, JDC; Perry, CG; Porter, J; Prete, A; Quinkler, M; Rees, DA; Reisch, N; Ross, RJM; Stikkelbroeck, NMML; Touraine, PA; Tschaidse, L1
Friedrich, C; Hartmann, MF; Kamrath, C; Wudy, SA1

Reviews

1 review(s) available for 17-alpha-hydroxyprogesterone and fludrocortisone

ArticleYear
Congenital adrenal hyperplasia: issues in diagnosis and treatment in children.
    Indian journal of pediatrics, 2014, Volume: 81, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenalectomy; Anti-Inflammatory Agents; Child; Fludrocortisone; Glucocorticoids; Humans; Hydrocortisone; Infant, Newborn; Neonatal Screening; Puberty

2014

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and fludrocortisone

ArticleYear
Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; 17-alpha-Hydroxyprogesterone; Adrenal Cortex Diseases; Adult; Aldosterone; Androstenedione; Desoxycorticosterone; Enzyme Inhibitors; Female; Fludrocortisone; Humans; Hydroxysteroid Dehydrogenases; Infusions, Intravenous; Kidney; Male; Middle Aged; Mineralocorticoids; Postmenopause; Potassium; Prednisolone; Prednisone; Progesterone; Sodium; Urodynamics

2003

Other Studies

23 other study(ies) available for 17-alpha-hydroxyprogesterone and fludrocortisone

ArticleYear
Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
    Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adrenal Hyperplasia, Congenital; Age Factors; Atrial Natriuretic Factor; Blood Pressure; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fludrocortisone; Humans; Hydrocortisone; Hydroxyprogesterones; Infant; Renin; Sodium; Water-Electrolyte Balance

1992
[Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Deutsche medizinische Wochenschrift (1946), 1988, Dec-09, Volume: 113, Issue:49

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Child; Child, Preschool; Female; Fludrocortisone; Humans; Hydrocortisone; Hydroxyprogesterones; Infant; Male; Monitoring, Physiologic; Radioimmunoassay; Saliva

1988
Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
    Annals of the New York Academy of Sciences, 1985, Volume: 458

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Child; Child, Preschool; Female; Fludrocortisone; Follow-Up Studies; Growth; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Renin-Angiotensin System; Sexual Maturation; Steroid Hydroxylases; Testosterone; Time Factors

1985
Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 56, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Androgens; Angiotensin II; Dexamethasone; Fludrocortisone; Humans; Hydroxyprogesterones; Male; Posture; Steroid Hydroxylases

1983
Plasma renin activity in the management of congenital adrenal hyperplasia.
    Archives of disease in childhood, 1984, Volume: 59, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Child; Child, Preschool; Female; Fludrocortisone; Humans; Hydroxyprogesterones; Male; Renin; Sodium; Testosterone

1984
Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Hormone research, 1997, Volume: 47, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Age Determination by Skeleton; Androstenedione; Body Height; Body Weight; Child, Preschool; Cortisone; Female; Fludrocortisone; Growth; Humans; Infant; Male

1997
Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
    Clinical endocrinology, 1997, Volume: 46, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Body Height; Dexamethasone; Female; Fertility; Fludrocortisone; Glucocorticoids; Humans; Mineralocorticoids; Ovulation; Pregnancy; Progesterone; Saliva; Testosterone; Treatment Outcome; Vagina

1997
Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocorticotropic Hormone; Body Composition; Dexamethasone; Estradiol; Female; Fertility; Fludrocortisone; Humans; Hydrocortisone; Laparoscopy; Menstrual Cycle; Progesterone; Time Factors; Treatment Outcome; Weight Loss

2001
Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene.
    European journal of endocrinology, 2001, Volume: 144, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Aldosterone; Cytochrome P-450 CYP11B2; DNA; Female; Fludrocortisone; Heterozygote; Humans; Hydrocortisone; Infant, Newborn; Mixed Function Oxygenases; Mutation; Sequence Analysis, DNA

2001
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; Anti-Inflammatory Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fludrocortisone; Humans; Hydrocortisone; Male; Retreatment; Suspensions; Tablets; Therapeutic Equivalency

2001
Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:10

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Child; Dexamethasone; Female; Fludrocortisone; Hormone Replacement Therapy; Humans; Hydrocortisone; Male

2001
Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity.
    Fertility and sterility, 2004, Volume: 81, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Female; Fludrocortisone; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications; Saliva; Steroid 21-Hydroxylase

2004
Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Bone Density; Female; Fertility; Fludrocortisone; Glucocorticoids; Humans; Quality of Life

2008
Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
    Hormone research in paediatrics, 2010, Volume: 74, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Alleles; Androstenedione; Anti-Inflammatory Agents; Blood Pressure; DNA; DNA Mutational Analysis; Female; Fludrocortisone; Humans; Infant; Infant, Newborn; Male; Pilot Projects; Renin; Retrospective Studies; Steroid 21-Hydroxylase

2010
Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.
    Hormone research in paediatrics, 2011, Volume: 75, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adult; Androstenedione; Anti-Inflammatory Agents; Blood Specimen Collection; Child; Child, Preschool; Circadian Rhythm; Drug Monitoring; Fludrocortisone; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Reproducibility of Results

2011
Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Clinical genetics, 2012, Volume: 82, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Alleles; Child; Child, Preschool; Female; Fludrocortisone; Genetic Association Studies; Glucocorticoids; Humans; Hydrocortisone; Infant; Infant, Newborn; Male; Mineralocorticoids; Mutation; Neonatal Screening; Steroid 21-Hydroxylase

2012
A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Endocrine journal, 2015, Volume: 62, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Amino Acid Substitution; Anti-Inflammatory Agents; Binding, Competitive; Family Health; Fludrocortisone; Heme; Heterozygote; Humans; Hydrocortisone; Infant; Male; Parents; Point Mutation; Progesterone; Steroid 21-Hydroxylase; Substrate Specificity; Treatment Outcome; Up-Regulation

2015
Salt Losing Variety of Congenital Adrenal Hyperplasia--A Case Report.
    Mymensingh medical journal : MMJ, 2016, Volume: 25, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Bangladesh; Diagnosis, Differential; Fludrocortisone; Hormone Replacement Therapy; Humans; Hydrocortisone; Infant, Newborn; Male; Sodium Chloride

2016
Hypertension in children with congenital adrenal hyperplasia.
    Clinical endocrinology, 2016, Volume: 85, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Age Factors; Child; Child, Preschool; Female; Fludrocortisone; Humans; Hypertension; Infant; Infant, Newborn; Longitudinal Studies; Male; Retrospective Studies; Sex Factors

2016
Long-term Growth in Congenital Adrenal Hyperplasia.
    Indian journal of pediatrics, 2019, Volume: 86, Issue:2

    Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Body Height; Body Mass Index; Child; Electrolytes; Female; Fludrocortisone; Growth; Humans; Hydrocortisone; India; Male; Progesterone; Retrospective Studies; Sex Factors; Sexual Maturation; Testosterone; Treatment Outcome

2019
Congenital Adrenal Hyperplasia with Salt Wasting Crisis: A Case Report.
    JNMA; journal of the Nepal Medical Association, 2020, Volume: 58, Issue:221

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Diagnosis, Differential; Fludrocortisone; Humans; Infant; Long-Term Care; Male; Prednisolone; Steroid 21-Hydroxylase; Steroids; Water-Electrolyte Imbalance

2020
Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
    European journal of endocrinology, 2023, Jan-10, Volume: 188, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Fludrocortisone; Glucocorticoids; Humans; Hydrocortisone; Potassium; Renin; Sodium

2023
Metabotypes of congenital adrenal hyperplasia in infants determined by gas chromatography-mass spectrometry in spot urine.
    The Journal of steroid biochemistry and molecular biology, 2023, Volume: 231

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Androgens; Child; Child, Preschool; Female; Fludrocortisone; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Infant; Steroids

2023